𝔖 Bobbio Scriptorium

✦ LIBER ✦

Adjuvant capecitabine is at least as effective as fluorouracil plus leucovorin for survival in people with resected stage III colon cancer

✍ Scribed by C. Lamberti; T. Sauerbruch; A Glasmacher

Book ID: 116395005
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 81 KB
Volume: 31
Category: Article
ISSN: 0305-7372
DOI: 10.1016/j.ctrv.2005.09.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacoeconomic Analysis of Capecitabin

Pharmacoeconomic Analysis of Capecitabine versus 5-Fluorouracil/Leucovorin as Adjuvant Therapy for Stage III Colon Cancer in Taiwan

✍ Tzu-Chi Hsu; Hong-Hwa Chen; Ming-Chin Yang; Hwei-Ming Wang; Jye-Hann Chuang; Shu 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB

Adjuvant chemotherapy with oxaliplatin,

Adjuvant chemotherapy with oxaliplatin, in combination with fluorouracil plus leucovorin prolongs disease-free survival, but causes more adverse events in people with stage II or III colon cancer: Abstracted from: André T, Boni C, Mounedji-Boudiaf L, et al. Multicenter international study of oxaliplatin/5-fluorouracil/leucovorin in the adjuvant treatment of colon cancer (MOSAIC) investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350:2343–51

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 213 KB

Safety analysis of two different regimen

Safety analysis of two different regimens of uracil–tegafur plus leucovorin as adjuvant chemotherapy for high-risk stage II and III colon cancer in a phase III trial comparing 6 with 18

✍ Tsuchiya, Takashi; Sadahiro, Sotaro; Sasaki, Kazuaki; Kondo, Ken; Katsumata, Ken 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 284 KB